Zobrazeno 1 - 10
of 46
pro vyhledávání: '"PJ Ruane"'
Autor:
Brenda Homony, Claudine Duvivier, I Neves, Christine Katlama, Gordon Crofoot, Natalia Zakharova, Stefan Esser, Hedy Teppler, Xia Xu, Randi Y. Leavitt, Adriano Lazzarin, CR Mejia, M Mustafa, Olga Aleksandrovna Tsybakova, James H McMahon, Brian Conway, Juan Carlos Rondon, Faiza Ajana, TS Chow, M Oyanguren, EM Rojas, Jean-Michel Molina, A Avihingsanon, Carlos Perez, Koldo Aguirrebengoa, Karen T. Tashima, M Wolff, Yazdan Yazdanpanah, Eugenia Negredo, R Serrao, Richard James Moore, Carmen D. Zorrilla, Winai Ratanasuwan, C Echiverri, L Panther, Joel E. Gallant, Andri Rauch, HH Lin, Bernard Vandercam, Anthony John Scarsella, L Hercilla, A. Antinori, Pedro Cahn, Albrecht Stoehr, DE Sweet, Mariette E. Botes, Johannes R. Bogner, Hans Jaeger, Soumi Gupta, Olaf Degen, Nathan Clumeck, H. Hartl, PJ Ruane, Ckc Lee, Juergen K. Rockstroh, Richard Kaplan, N Roth, MF Lasso, Rassool, Gatell Jm, Markus Bickel, Nelson, M Moutschen, V Sotnikov, R Kaplan, Amanda Clarke, WH Sheng, Anchalee Avihingsanon, Doug Ward, L Vanderkerckhove, Daniel S Berger, Sasisopin Kiertiburanakul, Ghr Smith, Sandy L. Rawlins, Mohammed Rassool, A d'Arminio Monforte, Paul E. Sax, Margaret A. Johnson, F. Maggiolo, Fernando Maltez, Ramirez, Evgeny Voronin, Eyal Shahar, S Henn, Cheryl McDonald, A Ustianowski, MT Bloch, E Arathoon, Peter Sklar, LD Gonzalez, Enrique Ortega, Louis Sloan, Amneris E. Luque, Isabelle Poizot-Martin, M. H. Losso, Giuliano Rizzardini, Debbie Hagins, Lilly East, Andrea Gori, Matthias Cavassini, Princy Kumar, Isabel Cassetti, G. Di Perri, Benedetto Maurizio Celesia, Evelyn Rojas, S Ferret, Jerry L. Cade, KM Mullane, CB Hsiao, Dane Turner, Eugénio Teófilo, Bach-Yen Nguyen, Craig A. Dietz, Anthony Rodgers, Elena Orlova-Morozova, Z. Sthoeger, Jean-Guy Baril, Hila Elinav, I Khaertynova, JG Saraiva da Cunha, Carl J. Fichtenbaum, G Faetkanheuer, Peter Ruane, HC Tsai, R Iskandar Shah Raja Azwa, Lerato Mohapi, Firaya Nagimova, Keikawus Arastéh, J. Durant, JD Velez, Jacques Reynes, ST Lewis, Saag, Otto Sussmann, P. Cahn, D Changpradub, Mark Bloch, RM Novak, W Ratanasuwan, Kathleen Squires, Fiona Smaill, Larissa Wenning, Jose R. Arribas, Edwin DeJesus, Don Smith, JO Morales, A. Yakovlev, Sharon Walmsley, Carolina Eugenia Chahin, I Levy, Alexandra Calmy, David James Prelutsky, David M. Asmuth, Linos Vandekerckhove, J Troya, Antonio Antela, Alan Winston, Lizette Santiago, Juan Berenguer, Marcel Stoeckle, RA Castillo, Anita Rachlis
Publikováno v:
Lancet HIV
Lancet HIV, Elsevier, 2017, 4 (11), pp.e486-e494. ⟨10.1016/S2352-3018(17)30128-5⟩
LANCET HIV
The Lancet HIV, Vol. 4, No 11 (2017) pp. e486-e494
Lancet HIV, Elsevier, 2017, 4 (11), pp.e486-e494. ⟨10.1016/S2352-3018(17)30128-5⟩
LANCET HIV
The Lancet HIV, Vol. 4, No 11 (2017) pp. e486-e494
Summary Background Once daily regimens are preferred for HIV-1 treatment, to facilitate adherence and improve quality of life. We compared a new once daily formulation of raltegravir to the currently marketed twice daily formulation. Methods In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b080de940b6244d90b7b170ca487b8b0
https://hal.archives-ouvertes.fr/hal-01745628
https://hal.archives-ouvertes.fr/hal-01745628
Autor:
David E. Anderson, Thomas N. Kakuda, PJ Ruane, M Ramgopal, R Ryan, Bruce Coate, Cynthia Brinson, M Cho
Publikováno v:
HIV Medicine. 16:288-296
Objectives Following antiretroviral therapy failure, patients are often treated with a three-drug regimen that includes two nucleoside/tide reverse transcriptase inhibitors [N(t)RTIs]. An alternative two-drug nucleoside-sparing regimen may decrease t
Autor:
Wohl DA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Spinner CD; TUM School of Medicine and Health, Department of Clinical Medicine - Clinical Department for Internal Medicine II, University Medical Centre, Technical University of Munich, Munich, Germany., Flamm J; Kaiser Permanente, Sacramento, CA, USA., Hare CB; Kaiser Permanente, San Francisco, CA, USA., Doblecki-Lewis S; Division of Infectious Diseases, University of Miami, Miller School of Medicine, Miami, FL, USA., Ruane PJ; Ruane Clinical Research, Los Angeles, CA, USA., Molina JM; Infectious Diseases Department, Hopitaux Saint-Louis Lariboisière, University of Paris and INSERM U944, Paris, France., Mills A; Men's Health Foundation, Los Angeles, CA, USA., Brinson C; Central Texas Clinical Research, Austin, TX, USA., Ramgopal M; Midway Research Center, Fort Pierce, FL, USA., Clarke A; Royal Sussex County Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, UK., Crofoot G; The Crofoot Research Centre, Houston, TX, USA., Martorell C; The Research Institute, Springfield, MA, USA., Carter C; Gilead Sciences, Foster City, CA, USA. Electronic address: christoph.carter7@gilead.com., Cox S; Gilead Sciences, Foster City, CA, USA., Hojilla JC; Gilead Sciences, Foster City, CA, USA., Shao Y; Gilead Sciences, Foster City, CA, USA., Das M; Gilead Sciences, Foster City, CA, USA., Kintu A; Gilead Sciences, Foster City, CA, USA., Baeten JM; Gilead Sciences, Foster City, CA, USA., Grant RM; University of California San Francisco, San Francisco, CA, USA; San Francisco AIDS Foundation, San Francisco, CA, USA., Mounzer K; Philadelphia FIGHT Community Health Centres, Philadelphia, PA, USA., Mayer K; The Fenway Institute, Fenway Health, Boston, MA, USA; Department of Medicine, Beth Israel Deaconess Medical Centre/Harvard Medical School, Boston, MA, USA.
Publikováno v:
The lancet. HIV [Lancet HIV] 2024 Aug; Vol. 11 (8), pp. e508-e521. Date of Electronic Publication: 2024 Jul 14.
Autor:
Eron JJ; Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA., Little SJ; Division of Infectious Diseases, University of California, San Diego, CA, USA., Crofoot G; Crofoot Research Center, Houston, TX, USA., Cook P; Division of Infectious Diseases, East Carolina University, Greenville, NC, USA., Ruane PJ; Ruane Clinical Research, Los Angeles, CA, USA., Jayaweera D; Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA., VanderVeen LA; Clinical Virology, Gilead Sciences, Foster City, CA, USA., DeJesus E; Orlando Immunology Center, Orlando, FL, USA., Zheng Y; Clinical Pharmacology, Gilead Sciences, Foster City, CA, USA., Mills A; Men's Health Foundation, Los Angeles, CA, USA., Huang H; Biostatistics, Gilead Sciences, Foster City, CA, USA., Waldman SE; Division of Infectious Diseases, University of California, Davis, Sacramento, CA, USA., Ramgopal M; Midway Immunology and Research Center, Fort Pierce, FL, USA., Gorgos L; AXCES Research Group, Santa Fe, NM, USA., Collins SE; Clinical Development, Gilead Sciences, Foster City, CA, USA. Electronic address: sean.collins@gilead.com., Baeten JM; Clinical Development, Gilead Sciences, Foster City, CA, USA., Caskey M; Laboratory of Molecular Immunology, Rockefeller University, New York, NY, USA.
Publikováno v:
The lancet. HIV [Lancet HIV] 2024 Mar; Vol. 11 (3), pp. e146-e155. Date of Electronic Publication: 2024 Jan 30.
Autor:
Lawitz EJ; Texas Liver Institute and University of Texas Health, San Antonio, Texas., Bhandari BR; Delta Research Partners, LLC, Bastrop, Louisiana., Ruane PJ; Ruane Clinical Research Group, Inc, Los Angeles, California., Kohli A; Arizona Liver Health, Chandler, Arizona., Harting E; Gilead Sciences, Inc, Foster City, California., Ding D; Gilead Sciences, Inc, Foster City, California., Chuang JC; Gilead Sciences, Inc, Foster City, California., Huss RS; Gilead Sciences, Inc, Foster City, California., Chung C; Gilead Sciences, Inc, Foster City, California., Myers RP; Gilead Sciences, Inc, Foster City, California., Loomba R; UC San Diego, La Jolla, California. Electronic address: roloomba@ucsd.edu.
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2023 Jan; Vol. 21 (1), pp. 143-152.e3. Date of Electronic Publication: 2022 Jan 06.
Autor:
Harrison SA; Pinnacle Clinical Research, San Antonio, TX, United States., Ruane PJ; Ruane Clinical Research Group Inc., Los Angeles, CA, United States., Freilich B; Kansas City Research Institute, Kansas City, MO, United States., Neff G; Covenant Metabolic Specialists, LLC, Sarasota, FL, United States., Patil R; South Texas Research Institute, Edinburg, TX, United States., Behling C; University of California San Diego, CA, United States., Hu C; MedPace, INC, Cincinnati, OH, United States., Shringarpure R; Akero Therapeutics, South San Francisco, CA, United States., de Temple B; Akero Therapeutics, South San Francisco, CA, United States., Fong E; Akero Therapeutics, South San Francisco, CA, United States., Tillman EJ; Akero Therapeutics, South San Francisco, CA, United States., Rolph T; Akero Therapeutics, South San Francisco, CA, United States., Cheng A; Akero Therapeutics, South San Francisco, CA, United States., Yale K; Akero Therapeutics, South San Francisco, CA, United States.
Publikováno v:
JHEP reports : innovation in hepatology [JHEP Rep] 2022 Aug 23; Vol. 5 (1), pp. 100563. Date of Electronic Publication: 2022 Aug 23 (Print Publication: 2023).
Autor:
Harrison SA; Radcliffe Department of Medicine, University of Oxford, Oxford, UK; Pinnacle Clinical Research, San Antonio, TX, USA., Abdelmalek MF; Division of Gastroenterology and Hepatology, Duke University, Durham, NC, USA., Neff G; Covenant Research, Sarasota, FL, USA., Gunn N; Pinnacle Clinical Research, San Antonio, TX, USA., Guy CD; Department of Pathology, Duke University, Durham, NC, USA., Alkhouri N; Arizona Liver Health, Tucson, AZ, USA., Bashir MR; Department of Radiology and Medicine, Duke University, Durham, NC, USA., Freilich B; Kansas City Research Institute, Kansas City, MO, USA., Kohli A; Arizona Liver Health, Chandler, AZ, USA., Khazanchi A; Florida Research Institute, Lakewood Ranch, FL, USA., Sheikh MY; Fresno Clinical Research Center, Fresno, CA, USA., Leibowitz M; National Research Institute, Los Angeles, CA, USA., Rinella ME; Department of Medicine (Gastroenterology and Hepatology), Northwestern University, Chicago, IL, USA., Siddiqui MS; Virginia Commonwealth University, Richmond, VA, USA., Kipnes M; Diabetes & Glandular Disease Clinic, San Antonio, TX, USA., Moussa SE; Adobe Clinical Research, Tucson, AZ, USA., Younes ZH; Gastro One, Germantown, TN, USA., Bansal M; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Baum SJ; Excel Medical Clinical Trials, Boca Raton, FL, USA., Borg B; Southern Therapy and Advanced Research, Jackson, MS, USA., Ruane PJ; Ruane Clinical Research, Los Angeles, CA, USA., Thuluvath PJ; Mercy Medical Center, Baltimore, MD, USA., Gottwald M; NGM Biopharmaceuticals, South San Francisco, CA, USA., Khan M; NGM Biopharmaceuticals, South San Francisco, CA, USA., Chen C; NGM Biopharmaceuticals, South San Francisco, CA, USA., Melchor-Khan L; NGM Biopharmaceuticals, South San Francisco, CA, USA., Chang W; NGM Biopharmaceuticals, South San Francisco, CA, USA., DePaoli AM; NGM Biopharmaceuticals, South San Francisco, CA, USA., Ling L; NGM Biopharmaceuticals, South San Francisco, CA, USA. Electronic address: lling@ngmbio.com., Lieu HD; NGM Biopharmaceuticals, South San Francisco, CA, USA.
Publikováno v:
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2022 Jul; Vol. 7 (7), pp. 603-616. Date of Electronic Publication: 2022 Mar 21.
Autor:
Segal-Maurer S; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., DeJesus E; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., Stellbrink HJ; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., Castagna A; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., Richmond GJ; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., Sinclair GI; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., Siripassorn K; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., Ruane PJ; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., Berhe M; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., Wang H; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., Margot NA; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., Dvory-Sobol H; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., Hyland RH; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., Brainard DM; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., Rhee MS; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., Baeten JM; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.)., Molina JM; From NewYork-Presbyterian Queens, Flushing, NY (S.S.-M.); Orlando Immunology Center, Orlando (E.D.), and Fort Lauderdale (G.J.R.) - both in Florida; Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany (H.-J.S.); Vita-Salute University, San Raffaele Scientific Institute, Milan (A.C.); Prism Health North Texas (G.I.S.) and North Texas Infectious Diseases Consultants (M.B.) - both in Dallas; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand (K.S.); Ruane Clinical Research Group, Los Angeles (P.J.R.), and Gilead Sciences, Foster City (H.W., N.A.M., H.D.-S., R.H.H., D.M.B., M.S.R., J.M.B.) - both in California; the University of Paris and the Department of Infectious Diseases, St. Louis-Lariboisière Hospitals, Assistance Publique-Hôpitaux de Paris, Paris (J.-M.M.); and AlloVir, Cambridge, MA (D.M.B.).
Publikováno v:
The New England journal of medicine [N Engl J Med] 2022 May 12; Vol. 386 (19), pp. 1793-1803.
Autor:
Vesikari T; Nordic Research Network Ltd, Tampere, Finland., Finn A; Bristol Royal Hospital for Children, Bristol, United Kingdom., van Damme P; University of Antwerp-Center for the Evaluation of Vaccination, Universiteitsplein, Wilrijk, Belgium., Leroux-Roels I; Gent University, Gent, Belgium., Leroux-Roels G; Gent University, Gent, Belgium., Segall N; Clinical Research Atlanta, Stockbridge, Georgia., Toma A; Manna Research, Toronto, Ontario, Canada., Vallieres G; Manna Research, Quebec, Quebec, Canada., Aronson R; LMC Diabetes and Endocrinology, Toronto, Ontario, Canada., Reich D; Medicor Research Inc, Sudbury, Ontario, Canada., Arora S; Aventiv Research, Columbus, Ohio., Ruane PJ; Ruane Clinical Research Group Inc, Los Angeles, California., Cone CL; Montana Medical Research Inc, Missoula., Manns M; Medizinishe Hochschule, Hannover, Lower Saxony, Germany., Cosgrove C; St George's University Hospital NHS Foundation Trust, London, United Kingdom., Faust SN; NIHR Southampton Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, United Kingdom., Ramasamy MN; Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital and University of Oxford, Oxford, United Kingdom., Machluf N; VBI Vaccines Inc, Cambridge, Massachusetts., Spaans JN; VBI Vaccines Inc, Cambridge, Massachusetts., Yassin-Rajkumar B; VBI Vaccines Inc, Cambridge, Massachusetts., Anderson D; VBI Vaccines Inc, Cambridge, Massachusetts., Popovic V; VBI Vaccines Inc, Cambridge, Massachusetts., Diaz-Mitoma F; VBI Vaccines Inc, Cambridge, Massachusetts.
Publikováno v:
JAMA network open [JAMA Netw Open] 2021 Oct 01; Vol. 4 (10), pp. e2128652. Date of Electronic Publication: 2021 Oct 01.
Autor:
Ogbuagu O; School of Medicine, Yale University, New Haven, CT, USA. Electronic address: onyema.ogbuagu@yale.edu., Ruane PJ; Ruane Clinical Research, Los Angeles, CA, USA., Podzamczer D; HIV and STI Unit, Infectious Disease Department, Hospital Universitario de Bellvitge, Barcelona, Spain., Salazar LC; Hoag Medical Group, Newport Beach, CA, USA., Henry K; Hennepin Healthcare Research Institute, Minneapolis, MN, USA., Asmuth DM; School of Medicine, University of California Davis, Davis, CA, USA., Wohl D; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Gilson R; Centre for Clinical Research in Infection and Sexual Health, University College London, London, UK., Shao Y; Departments of Biometrics, Virology, and Clinical Research, Gilead Sciences, Foster City, CA, USA., Ebrahimi R; Departments of Biometrics, Virology, and Clinical Research, Gilead Sciences, Foster City, CA, USA., Cox S; Departments of Biometrics, Virology, and Clinical Research, Gilead Sciences, Foster City, CA, USA., Kintu A; Departments of Biometrics, Virology, and Clinical Research, Gilead Sciences, Foster City, CA, USA., Carter C; Departments of Biometrics, Virology, and Clinical Research, Gilead Sciences, Foster City, CA, USA., Das M; Departments of Biometrics, Virology, and Clinical Research, Gilead Sciences, Foster City, CA, USA., Baeten JM; Departments of Biometrics, Virology, and Clinical Research, Gilead Sciences, Foster City, CA, USA., Brainard DM; Departments of Biometrics, Virology, and Clinical Research, Gilead Sciences, Foster City, CA, USA., Whitlock G; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Brunetta JM; Maple Leaf Medical Clinic, Toronto, ON, Canada., Kronborg G; Department of Infectious Diseases, University of Copenhagen, Hvidovre Hospital, Denmark., Spinner CD; Technical University of Munich, Munich, Germany.
Publikováno v:
The lancet. HIV [Lancet HIV] 2021 Jul; Vol. 8 (7), pp. e397-e407.